Imunon, Inc. — Director's Dealing 2015

Mar 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2015-03-17

Reporting Person: Tumminello Timothy J (Controller)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-17	Option to Purchase Celsion Corporation Common Stock	$2.45	A	25000	Acquired	2025-03-17	Celsion Corporation Common Stock (25000)	Direct

Footnotes

F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.

F2: The option vests in thirds on March 17, 2015, March 17, 2016 and March 17, 2017